Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Henn Matthew R
See Remarks at Seres Therapeutics. Filing since 1 Dec 2020.
CIK 0001767321
Company
Date
Role
Action
Shares
Amount
Of holding
MCRB
Seres Therapeutics, Inc.
17 Aug 2026
See Remarks
Sold on a plan
81
$368.55
1.0%
MCRB
Seres Therapeutics, Inc.
18 May 2026
See Remarks
Sold on a plan
77
$579.81
1.0%
MCRB
Seres Therapeutics, Inc.
15 Feb 2026
See Remarks
Sold on a plan
89
$753.83
1.1%
MCRB
Seres Therapeutics, Inc.
15 Nov 2025
See Remarks
Sold on a plan
1,257
$21.75K
14.3%
MCRB
Seres Therapeutics, Inc.
18 Aug 2025
See Remarks
Sold on a plan
73
$1.22K
1.6%
MCRB
Seres Therapeutics, Inc.
16 May 2025
See Remarks
Sold on a plan
77
$560.56
1.7%
MCRB
Seres Therapeutics, Inc.
18 Feb 2025
See Remarks
Sold on a plan
3,953
$3.20K
4.5%
MCRB
Seres Therapeutics, Inc.
18 Nov 2024
See Remarks
Sold on a plan
927
$501.23
1.2%
MCRB
Seres Therapeutics, Inc.
28 Oct 2024
See Remarks
Sold on a plan
3,984
$2.75K
5.0%
MCRB
Seres Therapeutics, Inc.
16 Aug 2024
See Remarks
Sold on a plan
923
$775.32
1.4%
MCRB
Seres Therapeutics, Inc.
15 May 2024
See Remarks
Sold on a plan
891
$837.54
1.3%
MCRB
Seres Therapeutics, Inc.
16 Feb 2024
See Remarks
Sold on a plan
4,170
$4.50K
6.2%
MCRB
Seres Therapeutics, Inc.
30 Oct 2023
See Remarks
Sold on a plan
3,886
$5.25K
6.5%
MCRB
Seres Therapeutics, Inc.
1 Dec 2020
See Remarks
Sold, plan not stated
91,812
$2.48M
100%
14 decisions on file.
